ANDA 218467, held by Dr Reddys. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 218467 (Succinylcholine Chloride), held by Dr Reddys, was first approved by FDA on Jan 17, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 17, 2024 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride100MG/5ML (20MG/ML) ยท solution;intramuscular, intravenous | Succinylcholine Chloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters